Executive Summary
This digest covers 50 filings from July 29, 2026, dominated by Indian M&A, insolvency, and regulatory actions, alongside several US SPAC business combinations and Nasdaq delisting notices.
A key trend is the high volume of open offers and structured acquisitions in India (Niraj Cement, Duke Offshore, 5Paisa Capital), while US markets show significant SPAC activity (Westin Acquisition, PBT Land & Minerals) and two capital market withdrawals (Astral demerger, EFC scheme). Insider activity is sparse but notable in the US, including the dilution of existing Processa stockholders (to ~0.9% ownership), signaling extreme risk. Negative signals are concentrated: MT Educare, K-Lifestyle, and ICSA India are deep in insolvency with ongoing defaults; three US companies (SCWorx, Foxx Development, Celularity) received Nasdaq deficiency notices. Unusually, a major impersonation incident was reported in a CoC meeting (K-Lifestyle). On the positive side, significant capital raisings (Processa $200M, Catalyst Acquisition $200M), strategic re-routing (RPG Life Sciences restructuring with a $700M growth fund), and a transformative healthcare SPAC merger (Westin/FCHS) offer high-upside opportunities. The key recommendation is to avoid deeply distressed Indian insolvencies and watch for delisting catalysts in the US, while selectively targeting the structured exits and operational restructurings.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K · S-1
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from July 28, 2026.
Investment Signals (11)
- Processa Pharmaceuticals ↓ (BULLISH)▲
Acquired Vidya Therapeutics and raised $200M; Phase 2 data readouts for food allergy (2H27), CSU (1H28), and RMS (2H28). Cash runway into 2H29.
- Westin Acquisition Corp ↓ (BULLISH)▲
Announced $650M business combination with First Choice Healthcare (OTC: FCHS). Focus on longevity and preventative care; expected Nasdaq listing in Q4 2026.
- RPG Life Sciences ↓ (BULLISH)▲
Slump-sale of API business, $243 Cr investment by India Life Sciences Fund IV & Vistaject for 40% stake in subsidiary, plus $80 Cr acquisition of Actis Generics. Total growth fund commitment up to $700 Cr.
- Indo-National Limited ↓ (BULLISH)▲
Acquired 31.82% stake in defence electronics company Aidin Tech for Rs 34.99 Cr. Entry into a ₹25,000 Cr market growing at 12-14% CAGR.
- 5Paisa Capital ↓ (BULLISH)▲
Acquiring Giskard Datatech for Rs 121.57 Cr cash + share swap to strengthen digital investment ecosystem. GDPL's turnover doubled from Rs 7.66 Cr (FY23) to Rs 15.75 Cr (FY25).
- Siyaram Silk Mills ↓ (BULLISH)▲
NCLT sanctioned scheme to issue bonus Preference Shares from general reserves, rewarding shareholders while maintaining cash.
- SCWorx Corp ↓ (BEARISH)▲
Received Nasdaq delisting notice for MVPHS falling below $1M; has 180 days to comply but no plan yet.
- Foxx Development Holdings ↓ (BEARISH)▲
Received Nasdaq deficiency for MVLS ($35M threshold); must regain compliance by Jan 19, 2027.
- Celularity Inc ↓ (BEARISH)▲
Received Nasdaq bid price deficiency notice (below $1.00 for 30 days); cure period until Jan 19, 2027.
-
Withdrew proposed demerger of chemical business due to insufficient scale; reconsideration timeline undefined. [NEUTRAL/BEARISH]
- Inflection Point Acquisition Corp III ↓ (BEARISH)▲
Received redemption requests for 24.67 million shares (likely high % of trust) ahead of Air Water Ventures deal, signaling shareholder exit.
Risk Flags (10)
- MT Educare / Default & Insolvency↓ (CRITICAL)▼
Ongoing defaults since March 2021; total outstanding Rs 32.33 Cr. Under CIRP since Dec 2022. Coinvoked guarantees of Rs 23.99 Cr.
- K-Lifestyle & Industries / Impersonation & CIRP↓ [HIGH RISK]▼
Impersonator attended CoC meetings. CIRP expires Aug 15, 2026; 90-day extension sought. Resolution plan deadline Sept 2, 2026.
- ICSA India / Liquidation↓ [EXTREME RISK]▼
Zero revenue since FY2020; net losses widened to Rs 4,869.76 Lakh in Q3 FY20. Liquidation closed Feb 2023 after asset sales of Rs 10.23 Cr.
- ▼
Under CIRP since Feb 2024; NSDL/CDSL stopped providing beneficiary data due to non-payment. Cannot file quarterly compliance.
- Novartis India / Change of Control Risk↓ [MEDIUM RISK]▼
WaveRise/ChrysCapital (CC) purchased Novartis AG's stake. Entire board resigned. New promoters have no track record in pharma.
- Processa Pharmaceuticals / Extreme Dilution↓ (CRITICAL)▼
Existing stockholders diluted to ~0.9% post-deal. Vidya shareholders get 46%, new investors 52.6%. Massive dilution risk.
- PBT Land & Minerals / Complex SPAC / Rights Offering↓ [MEDIUM RISK]▼
Trust conversion eliminates cost exposure, but $71.2M backstop from SoftVest/Horizon Kinetics could be low. Shareholder approval required.
- Rainbow Children's Medicare / Weak Subsidiary Financials [MEDIUM RISK]▼
Subsidiary RWCHPL has negative net worth (-₹0.003 Cr) and declining revenue (FY24 vs FY25: -25%). Hospital completion in FY28.
- ECS Biztech / Low Underlying Price↓ [MEDIUM RISK]▼
Open offer at Rs 10.50 vs share purchase agreement price of Rs 2.26 for controlling stake—huge gap between controlling and public valuations.
- Enforcement Actions (Madhav Copper & Akash Infra-Projects) [HIGH RISK]▼
SEBI issued orders for adjudication/enforcement. Potential fines or sanctions could impact reputation and valuation.
Opportunities (10)
- Processa Pharmaceuticals / VT-7208 Catalyst↓ (HIGH OPPORTUNITY)◆
Phase 1 BTKi data shows strong CNS penetration and safety; Phase 2 initiation in food allergy and CSU 2H26; cash to 2H29.
- Westin Acquisition Corp / Healthcare SPAC↓ (HIGH OPPORTUNITY)◆
$650M enterprise value for First Choice Healthcare; Nasdaq listing Q4 2026; focus on longevity and preventative care.
- RPG Life Sciences / Restructuring + Fund↓ (HIGH OPPORTUNITY)◆
$700 Cr growth commitment for subsidiary; Rs 80 Cr acquisition of Actis Generics adds portfolio; API business slump sale completes by Sept 30, 2026.
- 5Paisa Capital / GDPL Acquisition↓ (MEDIUM OPPORTUNITY)◆
Acquiring Giskard for Rs 121.57 Cr cash + share swap; GDPL's turnover doubled from Rs 7.66 Cr (FY23) to Rs 15.75 Cr (FY25).
- Ambuja Cements / ACC Merger↓ (MEDIUM OPPORTUNITY)◆
NCLT-directed shareholder meeting on Sept 29, 2026 to approve absorption of ACC. Consolidation strengthens cement dominance.
- Siyaram Silk Mills / Bonus Pref Shares↓ (MEDIUM OPPORTUNITY)◆
NCLT-sanctioned bonus issue from reserves—shareholder-friendly move.
- Kesar India / Real Estate Play↓ (SPECULATIVE OPPORTUNITY)◆
Acquiring 100% of Kesar Lands for Rs 155.86 Cr via share swap at Rs 900/share. Zero turnover asset, but strategic land acquisition for real estate/infrastructure.
- Transindia Real Estate / NCLT Scheme↓ (LOW OPPORTUNITY)◆
NCLT dispensed shareholder meeting for amalgamation of subsidiary; transaction simplifies structure.
- Aureus Greenway Holdings / Defense Tech↓ (MEDIUM OPPORTUNITY)◆
Acquiring Powerus via stock-for-stock with 599:1 exchange ratio; post-merger, Powerus Corporation will own autonomous systems/defense.
- Sunrise Mentors (CodingNinjas) / Info Edge (SPECULATIVE OPPORTUNITY)◆
Rs 10 Cr working capital infusion; FY26 turnover Rs 97.43 Cr despite negative net worth. Parent support may stabilize.
Sector Themes (6)
- Indian M&A Wave◆
15+ filings involve M&A/restructuring in India, spanning cement (Ambuja/ACC), pharma (RPG), real estate (Kesar), and digital (5paisa). Domestic companies using share swaps and structured deals. Regulatory complexity high (SEBI/NCLT approvals).
- Nasdaq Delisting Risk Cluster◆
Three US companies (SCWorx, Foxx Development, Celularity) received Nasdaq deficiency letters on the same week (July 22-24, 2026). This may reflect market-wide small-cap pressure or sector-specific headwinds.
- SPAC Activity Surge◆
Westin Acquisition, PBT Land & Minerals, Inflection Point III, Ocean Capital, and Catalyst Acquisition all filing material events. SPACs targeting healthcare, energy, and media—signals revival of M&A pipeline.
- Indian CIRP/Insolvency Logjam◆
MT Educare (CIRP since 2022), K-Lifestyle (expires Aug 15), SKIL Infrastructure (data freeze), ICSA India (liquidation closed)—multiple entities stuck in insolvency, highlighting systemic delays and asset recovery failures.
- Defence & Green Energy Diversification◆
Indo-National entering defence (₹25,000 Cr market); JK Cement investing in solar via SPV; Phoenix Mills investing in renewable energy—Indian corporates diversifying into defence and renewables.
- SEBI Enforcement Actions◆
Two adjudication orders (Madhav Copper, Akash Infra-Projects) on July 28, 2026 signal increased regulatory scrutiny on market manipulation and compliance in India.
Watch List (8)
-
Business combination with First Choice Healthcare; shareholder vote and SEC review; expected close Q4 2026. Monitor for regulatory hurdles.
-
Slump sale of API business (by Sept 30, 2026); Actis Generics acquisition (by Nov 15, 2026); $700 Cr fund infusion. Execution risk high.
-
Nasdaq compliance deadline Jan 20, 2027; board evaluating options. Watch for any capital structure changes or reverse stock split.
-
Nasdaq bid price cure period until Jan 19, 2027. Monitor if they execute a reverse split or get additional extension.
-
Nasdaq MVLS compliance by Jan 19, 2027. Monitor market value and potential strategic actions.
-
CIRP deadline Aug 15, 2026; 90-day extension sought; resolution plan submission deadline Sept 2, 2026. Watch for bid outcomes.
-
High redemptions (24.67M shares); service provider agreement filed. Monitor whether Air Water Ventures deal closes or liquidates.
- Rainbow Children's Medicare👁
Seeking Q1 FY28 for Malad hospital launch; Pune hub in FY29. Monitor financial performance of subsidiary RWCHPL.
Filing Analyses
(50)
29-07-2026
The Committee of Independent Directors (IDC) of Niraj Cement Structurals Limited has recommended that shareholders accept the open offer from Gulshankumar Vijaykumar Chopra to acquire up to 1,55,20,529 equity shares (26% of voting capital) at ₹29 per share. The IDC found the offer price fair and reasonable, noting it is higher than the 60-day volume-weighted average market price and consistent with the consideration paid in share purchase agreements. However, the IDC advised shareholders to independently evaluate the offer before making a decision.
- · The IDC members hold no equity shares in the target company and have no relationship with the acquirer.
- · No independent advisor was appointed by the IDC.
- · The advertisement was published on July 29, 2026, in Financial Express (English), Jansatta (Hindi), and Navshakti (Marathi).
- · The offer is made under Regulation 3(1) of SEBI (SAST) Regulations, 2011.
29-07-2026
Indo-National Limited (INL) has acquired a 31.82% stake in Aidin Technologies Private Limited, a defence electronics company, for an aggregate consideration of ₹34,99,92,034 (₹34.99 Cr). The acquisition is structured in two tranches, with Tranche 1 completed on July 29, 2026, and Tranche 2 expected by July 28, 2027. This investment marks INL's entry into the defence and aerospace sector, which it describes as a ~₹25,000 Cr market growing at 12-14% CAGR, aiming to diversify its business beyond its traditional consumer focus.
- · Aidin Technologies was incorporated on May 2, 2008, and is engaged in radio frequency power electronics and embedded system technologies.
- · The acquisition is not a related party transaction; promoters/promoter group have no interest.
- · No governmental or regulatory approvals are required for the acquisition.
- · Consideration is in cash.
- · Tranche 2 is expected to be completed on or before July 28, 2027.
- · Aidin Technologies' turnover grew from ₹1,57,986 thousands in FY 2022-23 to ₹7,43,123 thousands in FY 2024-25, representing a 191.5% increase over two years.
29-07-2026
The Phoenix Mills Limited, along with its subsidiary Offbeat Developers Private Limited, has entered into an amendment to the Security Subscription and Shareholders' Agreement (SSSA) with JSW Neo Energy Limited and O2 Renewable Energy XXVIII Private Limited to invest a total of ₹5,76,90,000 in equity shares and Series B Compulsory Convertible Debentures of O2 Renewable XXVIII. The investment is aimed at meeting captive user requirements for solar power under the Electricity Act, 2003, and will enable the company to consume renewable energy generated by the captive plant. The target entity, O2 Renewable XXVIII, is a newly incorporated company with no turnover and negative net worth, reflecting its early-stage development.
- · The acquisition does not fall within related party transactions, and the promoter/promoter group has no interest in O2 Renewable XXVIII.
- · The combined shareholding of Phoenix Mills and Offbeat in O2 Renewable XXVIII will not exceed 45% on a fully diluted basis.
- · O2 Renewable XXVIII was incorporated on July 31, 2024, and has no turnover for FY 2025-26; its net worth is negative at ₹-3,128.87 thousand as of FY 2025-26.
- · The completion of the acquisition is expected within 30 business days from the execution of the amendment to the SSSA.
29-07-2026
29-07-2026
Info Edge (India) Limited has approved an investment of about Rs. 10 Crores in its wholly-owned subsidiary Sunrise Mentors Private Limited ('CodingNinjas') to meet the subsidiary's working capital requirements. The investment will be made via cash consideration for 18,725 equity shares at an issue price of Rs. 5,340.23 each. CodingNinjas reported a turnover of Rs. 97.43 Crores for FY2025-26 but recorded a net loss of Rs. 13.36 Crores and negative net worth of Rs. 34.98 Crores as of March 31, 2026.
- · CodingNinjas has negative net worth of Rs. 34.98 Crores as of March 31, 2026.
- · The investment is to meet working capital requirements of the subsidiary.
- · The transaction is classified as a related party transaction but done at arm's length.
- · Completion of the acquisition is expected within 30 days from the approval.
- · The issue price per share is Rs. 5,340.23 including a premium of Rs. 5,330.23.
29-07-2026
Westin Acquisition Corp (Nasdaq: WSTNU) announced a definitive business combination agreement with First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) to create a publicly traded healthcare and wellness company. The transaction values First Choice at a pro forma enterprise value of approximately $650 million and is expected to close in Q4 2026. The combined company will rebrand as Wellgevity 360, focusing on longevity, preventative care, and personalized medicine, and will trade on Nasdaq.
- · The transaction implies a pre-money equity value of approximately $650 million for First Choice Healthcare.
- · The combined company is expected to trade on Nasdaq.
- · Transaction expected to close in Q4 2026, subject to regulatory and shareholder approvals.
- · Westin will domesticate from the Cayman Islands to Nevada prior to closing.
- · The global wellness economy is forecast to reach $9.8 trillion by 2029 at a 7.6% annual growth rate.
- · Millennials and Gen Z are driving a 'prejuvenation' trend in the wellness market.
- · The business model emphasizes cash-pay services to reduce insurance dependency and membership programs for recurring revenue.
29-07-2026
PBT Land & Minerals, Inc. filed an S-4 registration statement to solicit unitholder approval for a business combination that would acquire the majority of assets and liabilities of Permian Basin Royalty Trust and approximately 68,000 acres of surface estate with a 15% effective royalty interest from Blackbeard Holdings. The transaction will convert the Trust's 75% net overriding royalty interest into a cost-free 15% royalty, eliminating cost exposure and providing more predictable cash flow. Concurrently, a rights offering with a $71.2 million backstop commitment from SoftVest and Horizon Kinetics will allow unitholders to subscribe for additional Class A shares, with Blackbeard entities subscribing for a 40.7% pro rata portion. Following the deal, former unitholders will own 59.3% of New PBT common stock, while Blackbeard entities will own 40.7%.
- · The Trust's 75% net overriding royalty interest in Waddell Ranch will be converted into a cost-free 15% effective royalty interest, eliminating cost exposure.
- · New PBT will acquire approximately 68,000 acres of surface estate and a 15% effective royalty interest from Blackbeard Holdings.
- · SoftVest, L.P. beneficially owns approximately 13.3% of outstanding Trust Units.
- · SoftVest, L.P. will sell New PBT to the Trust for one dollar before consummation of the Business Combination.
- · The Rights Offering includes a backstop commitment of up to $71.2 million from SoftVest and Horizon Kinetics.
- · Blackbeard Security and Greybeard Energy will subscribe for Class A shares representing a combined 40.7% pro rata portion of New PBT post-closing.
- · Following the Business Combination, former unitholders will own 59.3% and Blackbeard entities will own 40.7% of New PBT common stock.
- · The Trust will terminate and Trust Units will be delisted from NYSE and deregistered under the Exchange Act.
- · Class A Shares are expected to be listed on NYSE and NYSE Texas under symbol 'PBT'.
- · The Trustee has not made any recommendation for or against the proposals.
29-07-2026
Iron Horse Acquisition II Corp. (IRHO) and Electra Vehicles, Inc. (Electra) announced that Electra AI contributed to a Volta Foundation insights paper on battery storage in data center applications. The paper argues that AI buildout is now gated by power delivery speed, with battery storage (BESS) deployable in 12-18 months versus multi-year waits for gas turbines and transformers. This is a non-financial, forward-looking update with no quantitative financial data or period-over-period comparisons.
- · Battery storage (BESS) deployment timeline: 12-18 months vs. multi-year waits for gas turbines and transformers.
- · Grid connections now take more than four years in most U.S. markets.
- · The paper maps where batteries win, compete, and fall short in data center applications.
- · Electra AI's platform focuses on real-time monitoring, optimization, and control of battery systems to maximize ROI and safety.
29-07-2026
Rising Dragon Acquisition Corp. (RDACU) issued a $55,637.41 promissory note to SZG Limited on June 15, 2026, to extend the time available to consummate its initial business combination. The note is non-interest bearing and convertible into private units at $10.00 per unit upon closing of the business combination. If the merger agreement is terminated under certain conditions or the business combination does not close, the note will be terminated with no amounts due.
- · The note is dated June 15, 2026, and the initial public offering prospectus is dated October 10, 2024.
- · The merger agreement with SZG Limited and other parties was signed on January 27, 2025.
- · Proceeds from the note must be deposited into the trust account to extend the time for the business combination.
- · No interest accrues on the note.
- · The note is governed by New York law and the parties waive jury trial rights.
- · The payee (SZG Limited) waives any claim against the trust account, limiting recourse to assets outside the trust.
29-07-2026
MT Educare Limited disclosed defaults on repayment of principal and interest to Prudence ARC and Axis Bank, with a total outstanding borrowing of ₹32.33 Crore. The company has been under Corporate Insolvency Resolution Process (CIRP) since December 16, 2022, and the defaults have been ongoing since March 2021. Additionally, there are invoked corporate guarantees totaling ₹23.99 Crore, and a rejected claim of ₹49.72 crore from Shamrao Vithal Co-op Bank Ltd is under appeal.
- · Defaults have been ongoing since March 2021.
- · CIRP commenced on December 16, 2022, per NCLT order.
- · Committee of Creditors was constituted on August 21, 2023.
- · Arihant Nenawati was appointed as Resolution Professional on January 22, 2024.
- · The rejected claim of ₹49.72 crore from Shamrao Vithal Co-op Bank Ltd is under appeal at NCLAT.
29-07-2026
Nasdaq notified SCWorx Corp. on July 24, 2026, that its Market Value of Publicly Held Shares (MVPHS) fell below the minimum $1 million requirement for 30 consecutive trading days (June 10 to July 23, 2026), violating Nasdaq Listing Rule 5550(a)(5). The company has a 180-day compliance period until January 20, 2027, to regain compliance, and management is evaluating alternatives but has not yet determined a course of action. There is no assurance that SCWorx will be able to regain compliance or maintain its Nasdaq listing.
- · The compliance period ends on January 20, 2027.
- · Nasdaq may require MVPHS compliance for up to 20 consecutive business days before confirming long-term compliance.
- · The board of directors has not yet decided on any alternative to regain compliance.
- · If compliance is not regained, Nasdaq will issue a delisting notice; the company may appeal to a hearings panel.
29-07-2026
Inflection Point Acquisition Corp. III disclosed that as of July 27, 2026, it had received redemption requests for 24,673,661 of its Class A ordinary shares in connection with its pending business combination with Air Water Ventures Holdings Limited. The company also entered into an agreement with a service provider to pay a cash fee equal to 125,000 multiplied by the redemption price, contingent on the service provider holding 125,000 non-redeemed shares at closing; however, as of the filing date, the service provider had not yet purchased any shares. The high redemption volume indicates significant shareholder exit, while the service provider incentive aims to reduce redemptions.
- · The service provider agreement requires the provider to show evidence within five business days of closing that it held 125,000 non-redeemed Class A ordinary shares.
- · Any subsequent share purchases by the service provider would be made at prices not exceeding the redemption price.
- · The registration statement for the business combination was declared effective by the SEC on July 8, 2026.
- · The record date for shareholder voting on the business combination was June 24, 2026, with proxy mailing beginning July 9, 2026.
29-07-2026
SKIL Infrastructure Ltd, under CIRP since February 1, 2024, has informed exchanges that it cannot submit quarterly compliance certificates (shareholding pattern, audit report, investor complaints) for the quarter ended June 30, 2026, because NSDL, CDSL, and its RTA have stopped providing beneficiary data due to non-payment of outstanding fees by the erstwhile management. The NCLAT stay on the constitution of the Committee of Creditors was vacated on October 15, 2025, and the CoC has since been constituted, with Mr. Purusottam Behera appointed as Resolution Professional.
- · CIRP commenced on February 1, 2024, via NCLT Mumbai order under Section 7 of IBC.
- · NCLAT stay on CoC constitution was vacated on October 15, 2025, and the appeal was withdrawn.
- · First CoC meeting held on November 3, 2025, approved appointment of IRP as RP.
- · Company is exempt from Regulations 17-21 of SEBI (LODR) under Regulations 15(2A) and 15(2B) due to CIRP status.
- · RP's IBBI registration is valid till December 31, 2026.
29-07-2026
PBT Land & Minerals, Inc. filed an S-1 registration statement on July 29, 2026, for a rights offering and business combination. The company plans to acquire a majority of Permian Basin Royalty Trust assets and oil/gas interests from Blackbeard Holdings and Greybeard Energy. The rights offering is expected to raise $120.0 million in gross proceeds, with a backstop commitment of up to $71.2 million from SoftVest and Horizon Kinetics. However, the offering is contingent on shareholder approval and completion of the business combination, and there is no public market for the shares yet.
- · The rights offering expires 25 days after issuance, with possible extension by the company.
- · Unitholders receive one Subscription Right per Trust Unit held as of the Record Date.
- · Over-Subscription Rights allow holders who fully exercise Basic Rights to buy additional unsubscribed shares pro rata.
- · Blackbeard Securities and Greybeard Energy have agreed to purchase Class A Shares in a private placement representing their pro rata portions (38.2% and 2.5% respectively).
- · The Backstop Purchasers (SoftVest and Horizon Kinetics) have jointly and severally committed to purchase up to $71.2 million of unsubscribed shares.
- · No public market exists for Class A Shares; expected to trade on NYSE and NYSE Texas under symbol 'PBT' after business combination.
- · The Board makes no recommendation regarding exercise of Subscription Rights.
- · Exercises of Subscription Rights are irrevocable once made, unless the offering is terminated.
29-07-2026
5paisa Capital Limited has revised its board meeting outcome to correct an error regarding the acquisition of Giskard Datatech Private Limited (GDPL). The company clarified that the acquisition of 100% of GDPL will be undertaken by 5paisa itself, not its promoters, through a combination of cash consideration of up to ₹1,21,57,49,108 and a share swap of 20,50,588 equity shares at a ratio of 1:31. The acquisition aims to strengthen 5paisa's digital investment ecosystem with advanced research and analytics capabilities, with GDPL's turnover growing from ₹7.66 crore in FY23 to ₹15.75 crore in FY25.
- · The Board meeting commenced at 8:30 p.m. and concluded at 9:30 p.m. on July 28, 2026.
- · The valuation report for Giskard was issued on June 18, 2026, by Mr. Raghav Mandhana (IBBI Registration No. IBBI/RV/06/2025/15965).
- · The acquisition is subject to SEBI approval due to Giskard's Research Analyst registration under SEBI (Research Analysts) Regulations, 2014.
- · The indicative time period for completion of the acquisition is up to 6 months.
- · The acquisition does not fall within related party transactions.
- · Giskard was incorporated on June 13, 2016, and primarily operates in India with no known overseas operations.
29-07-2026
5paisa Capital Limited has approved the acquisition of 100% of Giskard Datatech Private Limited for a total consideration comprising a cash component of ₹1,21,57,49,108 (₹121.57 Crore) and a share swap of 20,50,588 equity shares in a 1:31 ratio. The company also corrected an earlier filing error that incorrectly suggested promoters would acquire shares directly, clarifying that the acquisition will be undertaken by the company itself. The acquisition is expected to strengthen 5paisa's digital investment ecosystem by integrating Giskard's advanced research and analytics capabilities.
- · The share swap ratio is 1:31 (1 Giskard share for 31 5paisa shares).
- · The acquisition is subject to shareholder approval via postal ballot and regulatory approvals including SEBI (since Giskard holds a Research Analyst registration).
- · Completion timeline is up to 6 months.
- · The acquisition is not a related party transaction.
- · Giskard was incorporated on June 13, 2016, and operates in India with no known overseas presence.
29-07-2026
The 11th meeting of the Committee of Creditors (CoC) of K-Lifestyle & Industries Ltd. was held on July 23, 2026, with 80.28% voting share present, exceeding the quorum requirement. A serious incident of impersonation was reported, where an individual falsely attended CoC meetings as a suspended director, prompting the CoC to request an FIR. The CIRP period is set to expire on August 15, 2026, and the RP sought a 90-day extension as the resolution plan submission deadline (September 2, 2026) falls beyond the current timeline.
- · The impersonator attended the previous two CoC meetings as Mr. Jaiprakash Mishra before being discovered.
- · The actual Mr. Jaiprakash Mishra confirmed he has no association with the company and no active email address.
- · Suspended director Mr. Narayan Ramchandra Ghumatkar stated he forwards all CIRP communications to the Tayal Group and does not independently manage company matters.
- · The final list of eligible PRAs is scheduled to be issued on July 26, 2026.
- · The Information Memorandum, Evaluation Matrix, and Request for Resolution Plans are proposed to be issued on July 31, 2026.
- · The last date for submission of Resolution Plans is September 2, 2026.
- · Members of State Bank of India, Bank of India, and Punjab National Bank were absent without leave.
29-07-2026
Transindia Real Estate Limited has received an NCLT order dated July 15, 2026, directing it to issue notice to equity shareholders regarding the proposed Scheme of Amalgamation of its wholly owned subsidiary, Madanahatti Logistics and Industrial Parks Private Limited, with itself. The NCLT has dispensed with the requirement of a shareholder meeting for the transferee company, and shareholders have 30 days from receipt of notice to make representations. The filing is procedural and does not contain any financial figures or performance metrics.
- · NCLT Mumbai Bench order dated July 15, 2026, in Company Scheme Application No. C.A. (CAA)/232/MB-III/2025.
- · NCLT dispensed with the requirement of convening a meeting of equity shareholders of the transferee company (Transindia Real Estate Limited).
- · Shareholders have 30 days from receipt of notice to make representations to the NCLT.
- · Cut-off date for determining shareholders entitled to notice: July 17, 2026.
- · Documents available for inspection on company website and at registered office on working days between 2:00 p.m. and 4:00 p.m.
29-07-2026
Processa Pharmaceuticals, Inc. (PCSA) announced the acquisition of Vidya Therapeutics, Inc., adding the next-generation BTK inhibitor VT-7208 to its pipeline. Concurrently, the company secured an oversubscribed private placement of approximately $200 million from a syndicate of leading healthcare investors. The combined cash is expected to fund operations into the second half of 2029, with Phase 2 proof-of-concept data anticipated in food allergy (2H 2027), CSU (1H 2028), and RMS (2H 2028). However, existing Processa stockholders will be diluted to only about 0.9% ownership on a fully-diluted basis, while Vidya equity holders and new investors will own approximately 46.0% and 52.6%, respectively.
- · VT-7208 is a CNS-penetrant, once-daily, oral covalent BTKi designed to minimize off-target kinase activity and reduce hepatotoxicity risk relative to earlier BTKis.
- · In Phase 1, VT-7208 demonstrated robust target engagement, durable pharmacodynamic activity, and predictable dose-dependent pharmacokinetics in both CSF and periphery, with no serious adverse events.
- · Processa expects to initiate Phase 2 studies in food allergy and CSU in 2H 2026, and in RMS in 1H 2027.
- · The acquisition and private placement closings are not subject to Processa stockholder approval; stockholder approval is required only for conversion of the Series A preferred stock.
- · Processa intends to continue development of legacy assets PCS499 and PCS12852 alongside the BTK inhibitor program.
29-07-2026
Aspect Global Ventures Private Limited has launched a mandatory open offer to acquire up to 25,62,872 equity shares (26% of voting capital) of Duke Offshore Limited at ₹30 per share, aggregating ₹7,68,86,160. The offer opens on August 6, 2026 and closes on August 19, 2026, and is not conditional on any minimum acceptance level. The offer follows a substantial acquisition and change in control under SEBI (SAST) Regulations.
- · The offer is mandatory under Regulations 3(1) and 4 of SEBI (SAST) Regulations, 2011 for substantial acquisition and change in control.
- · The offer is not conditional on any minimum level of acceptance.
- · No competing offer has been made as of the letter date.
- · The Identified Date for determining eligible shareholders is July 23, 2026.
- · The last date for upward revision of offer price/size is August 4, 2026.
- · The Acquirer may withdraw the offer only under specific conditions (e.g., statutory approvals refused, death of natural person acquirer, agreement rescinded, or SEBI Board approval).
- · If oversubscribed, acceptance will be on a proportionate basis.
- · The marketable lot of Duke Offshore equity shares is 1 share.
29-07-2026
Dhiren Chandulal Shah and Sunil Chinubhai Shah (the Acquirers), along with 10 persons acting in concert (PACs), have launched an open offer to acquire up to 23,46,250 equity shares (face value ₹10 each) of Parmax Pharma Limited, representing 26.00% of the expanded voting share capital, from public shareholders. The pre-offer advertisement was published on July 29, 2026, in Financial Express (English, all editions), Jansatta (Hindi, all editions), Financial Express (Gujarati, Ahmedabad edition), and Mumbai Lakshdeep (Marathi, Mumbai edition). The offer is managed by Fedex Securities Private Limited and is made under SEBI (SAST) Regulations, 2011.
- · The pre-offer advertisement was published on July 28, 2026, and submitted to BSE on July 29, 2026.
- · The offer is for up to 23,46,250 fully paid-up equity shares of face value ₹10 each.
- · The target company is Parmax Pharma Limited (Scrip ID: PARMAX, Scrip Code: 540359).
- · The offer is made under Regulation 18(7) of the SEBI (SAST) Regulations, 2011.
- · Newspapers used: Financial Express (English, all editions), Jansatta (Hindi, all editions), Financial Express (Gujarati, Ahmedabad edition), Mumbai Lakshdeep (Marathi, Mumbai edition).
28-07-2026
SEBI issued an adjudication order against Madhav Copper Limited on July 28, 2026, in an enforcement matter. The filing does not disclose the specific penalty amount or nature of the violation, but the action represents a regulatory enforcement proceeding by the securities market regulator.
- · The adjudication order was issued by SEBI's Adjudication Officer (AO).
- · The order is categorized under 'Orders of AO' in SEBI's enforcement section.
- · No specific financial penalty, violation details, or monetary amount is provided in the filing.
28-07-2026
SEBI issued an adjudication order on July 28, 2026, regarding market manipulation in the scrip of Akash Infra-Projects Limited. The order details enforcement actions taken by SEBI against parties involved in the manipulation. No financial penalties or specific findings are disclosed in the filing.
- · The order was issued by SEBI's Adjudication Officer (AO) under the enforcement division.
- · The case involves alleged market manipulation in the trading of Akash Infra-Projects Limited shares.
29-07-2026
Systematix Corporate Services Limited has invested ₹2,50,00,000 (₹2.5 Cr) in its wholly owned subsidiary Systematix Wealth & Asset Services Private Limited (SWASPL) by subscribing to 25,00,000 equity shares at ₹10 each via a rights issue. The investment is intended to meet the working capital requirements of SWASPL, which focuses on Alternative Investment Funds, wealth management, and distribution services. While SWASPL's turnover surged from nil in FY2024-25 to ₹193.06 Lakhs in FY2025-26, it had virtually no revenue in the prior two years, indicating a nascent but rapidly growing business.
- · SWASPL was originally incorporated as Systematix Ventures Private Limited and later renamed to Systematix Wealth & Asset Management Private Limited before its current name.
- · SWASPL holds registrations from AMFI and SEBI as a Portfolio Manager.
- · The transaction is classified as a related party transaction but is stated to be at arm's length.
- · The promoter/promoter group has no interest in SWASPL beyond shareholding and directorship.
- · No governmental or regulatory approvals are required for this acquisition.
- · The investment is in cash consideration.
29-07-2026
Go Digit General Insurance Limited announced that the Competition Commission of India (CCI) has approved the proposed amalgamation of Go Digit Infoworks Services Private Limited into Go Digit General Insurance Limited under Section 31(1) of the Competition Act, 2002. The approval, received on 28 July 2026, follows earlier no-adverse-observation letters from stock exchanges. The scheme remains subject to further approvals from the NCLT, IRDAI, and shareholders, and the detailed CCI order is awaited.
- · CCI approval received on 28 July 2026 under Section 31(1) of the Competition Act, 2002.
- · Stock exchanges had previously issued observation letters with 'no adverse observations' on 23 April 2026.
- · The scheme was initially approved by the Board of Directors on 19 December 2025.
- · Pending approvals: NCLT, IRDAI, and shareholders.
29-07-2026
Inventurus Knowledge Solutions Limited disclosed the incorporation of a step-down wholly owned subsidiary, Value Partners Collective ACO, LLC (VPCA), in the United States. VPCA was incorporated on May 5, 2026, with zero capitalization and no revenue, and its purpose is to apply for the CMS LEAD program, a voluntary 10-year value-based healthcare model. The filing notes that VPCA has no immediate material financial impact and will be dissolved if not selected by CMS.
- · VPCA is a single-member LLC, 100% owned by IKS Inc.
- · VPCA's office is at 8951 Cypress Waters Blvd, Suite 100 Coppell TX 75019, USA.
- · If VPCA is not selected for the LEAD program, the entity will be dissolved.
- · The incorporation does not constitute a related party transaction.
- · No governmental or regulatory approvals are required for the acquisition.
29-07-2026
Astral Limited's Board, following an independent consultant's review and stakeholder feedback, has decided to withdraw the proposed Composite Scheme of Arrangement (demerger of the Chemical Business). The Board concluded the demerger is not in the best interests of the company and its shareholders at this stage, citing the current scale of the Chemical Business. The company will reconsider the demerger once the Chemical Business achieves sufficient scale and financial strength.
- · The Board meeting commenced at 04:00 P.M. and concluded at 04:30 P.M. on July 29, 2026.
- · The independent consultant was appointed following earlier board decisions on June 25, 2026 and July 5, 2026.
- · The consultant evaluated both the current Composite Scheme and other restructuring options.
- · The Board considered feedback from shareholders, investors, and other market participants.
- · The demerger may be reconsidered once the Chemical Business achieves scale and financial strength to fund its own growth.
29-07-2026
The National Company Law Tribunal (NCLT), Mumbai Bench, has sanctioned the Scheme of Arrangement between Siyaram Silk Mills Limited and its shareholders under Section 230 of the Companies Act, 2013. The scheme involves issuing bonus Preference Shares to equity shareholders using the company's general reserves, rewarding shareholders while maintaining sufficient cash for business needs. The scheme was approved by equity shareholders and unsecured creditors with no objections from any party.
- · The scheme was approved by the Board of Directors on 26.10.2024.
- · Meetings of equity shareholders and unsecured creditors were held on 29.12.2025.
- · The meeting of secured creditors was dispensed with due to consent affidavits.
- · The company received observation letters from BSE (11.07.2025) and NSE (07.07.2025) under Regulation 37 of SEBI Listing Regulations.
- · The Regional Director, Ministry of Corporate Affairs, filed a report dated 15.04.2026 with observations, all of which were addressed by the company.
- · No inquiries, inspections, investigations, or prosecutions are pending against the company under the Companies Act, 2013.
- · The company undertakes to comply with directions from sectoral regulators, Income Tax Department, and GST Department.
29-07-2026
Allcargo Global Ltd's wholly owned subsidiary, Ecu Global N.V., acquired the remaining 10% stake in ECUnordicon AB for SEK 17,600,000 (cash consideration), increasing its holding to 100%. The target entity, a Swedish multimodal transportation and warehousing company, reported a net revenue of SEK 462,555,733 for Jan-Dec 2025, down from SEK 541,851,764 in the prior year, reflecting a decline of approximately 14.6% YoY.
- · The acquisition was executed via a put option in a shareholders agreement dated July 29, 2021.
- · ECUnordicon AB was incorporated on July 7, 2021.
- · The acquisition is not a related party transaction.
- · No governmental or regulatory approvals were required.
- · The company's website provides further details: https://www.allcargo.global.
29-07-2026
The board of Novartis India took on record the completion of the open offer by WaveRise Investments, ChrysCapital Fund X and Two Infinity Partners (collectively 'CC'), pursuant to which Novartis AG sold 17,450,680 equity shares to CC and ceased to be a promoter/controller. The board appointed three new non-independent directors (Mr. Ashok Bhatia, Mr. Kshitij Sheth, Dr. Jagriti Gupta) and three new independent directors (Mr. Ramesh Ramadurai, Mr. Shashank Sinha, Ms. Suchita Sharma), while accepting the resignations of six directors including the chairperson, CFO and two independent directors.
- · Transaction completed on July 29, 2026 (Closing Date).
- · New promoters are WaveRise Investments Limited and ChrysCapital Fund X.
- · Novartis AG reclassified from 'promoter' to 'public' category.
- · Committee of Independent Directors constituted on June 4, 2026 for open offer; recommendations published June 6, 2026.
- · Board composition remains compliant with Companies Act, 2013 and SEBI Listing Regulations.
29-07-2026
EFC (I) Limited announced that its material wholly owned subsidiary, EFC Limited, along with three step-down subsidiaries, has withdrawn the proposed Scheme of Arrangement for Demerger that was originally intended to be implemented via the fast-track merger route. The withdrawal was approved by the respective boards on July 29, 2026, citing prevailing legal and regulatory framework, operational requirements, and overall business considerations. An application to formally withdraw the scheme will be filed with the Hon’ble Regional Director, Mumbai.
- · The demerger scheme was initially disclosed on December 24, 2024.
- · The scheme was proposed under Section 233 of the Companies Act, 2013 (Fast Track Merger).
- · Withdrawal was approved by the boards of EFC Limited and the three step-down subsidiaries on July 29, 2026.
- · An application to withdraw the Scheme will be filed with the Hon’ble Regional Director, Mumbai.
29-07-2026
Ambuja Cements Limited has received an order from the NCLT, Ahmedabad Bench, directing it to convene a meeting of equity shareholders on September 29, 2026, to consider and approve the Scheme of Amalgamation of ACC Limited (Amalgamating Company) with Ambuja Cements Limited (Amalgamated Company). The scheme, effective from January 1, 2026, involves the dissolution of ACC without winding up and issuance of new equity shares to ACC shareholders based on a share exchange ratio. Ambuja Cements, which already holds 50.05% of ACC's equity, will absorb ACC as a going concern, consolidating its position in the cement industry.
- · The appointed date for the amalgamation is January 1, 2026.
- · ACC Ltd. has no secured creditors and no preference shareholders as on March 31, 2026.
- · ACC Ltd. has 2,35,988 equity shareholders as on March 31, 2026.
- · Ambuja Cements Ltd. has 6,13,421 equity shareholders as on April 10, 2026.
- · Ambuja Cements' equity shares are listed on NSE and BSE; its GDRs are listed on the Luxembourg Stock Exchange.
- · The scheme follows prior amalgamations of Adani Cementation Limited (effective August 1, 2025), Sanghi Industries Limited (effective March 12, 2026), and Penna Cement Industries Limited (effective April 10, 2026) into Ambuja Cements.
29-07-2026
ACC Limited (Amalgamating Company) received an order from NCLT Ahmedabad Bench on July 29, 2026, directing it to convene a meeting of equity shareholders on September 29, 2026, to consider and approve the Scheme of Amalgamation with its holding company Ambuja Cements Limited (Amalgamated Company), effective from the appointed date of January 1, 2026. The order was issued in a joint company application under Sections 230-232 of the Companies Act, 2013. As of March 31, 2026, ACC had 2,35,988 equity shareholders, no secured creditors, and total outstanding unsecured debt of Rs.4950.67 Crore, but an excess of assets over liabilities of Rs.20,416.35 Crore.
- · The appointed date for the scheme is January 1, 2026.
- · ACC Limited was incorporated on 01.08.1936 as The Associated Cement Companies Ltd., name changed to ACC Ltd. on 01.09.2006, registered office shifted from Maharashtra to Gujarat on 18.03.2024.
- · Ambuja Cements Limited was incorporated on 20.10.1981, has undergone multiple name changes, and its GDRs are listed on the Luxembourg Stock Exchange.
- · The issued share capital of ACC includes 10,05,980 equity shares difference (unallotted, forfeited, kept in abeyance) largely from right issues in FY1995 and FY1999.
- · Ambuja Cements has 13,39,613 equity shares represented by global depository receipts as of May 31, 2026.
29-07-2026
Mr. Rakesh Ramanlal Shah and Komal Infotech Private Limited (PAC) have triggered an open offer for ECS Biztech Ltd, offering to acquire up to 53,44,313 equity shares (26% of voting capital) at ₹10.50 per share, aggregating to ₹5,61,15,286.50. The offer follows a share purchase agreement to acquire 1,34,46,936 shares (65.42% of the company) from the existing promoter group at ₹2.26 per share, totaling ₹3,03,90,076, which will give the acquirers control. The open offer price of ₹10.50 is significantly higher than the underlying transaction price of ₹2.26, reflecting a premium for public shareholders.
- · The open offer is not conditional upon any minimum level of acceptance.
- · The acquirers do not intend to delist the target company pursuant to this open offer.
- · The detailed public statement (DPS) is to be published on or before August 5, 2026.
- · The underlying transaction price of ₹2.26 per share is substantially lower than the open offer price of ₹10.50 per share.
- · The selling shareholders (Vijay Mansinhbhai Mandora, Seema Vijay Mandora, Achal Vijaysinh Mandora, Mandora Finserve Private Limited) are part of the promoter group and will sell their entire holdings.
29-07-2026
Power Grid Corporation of India Limited (POWERGRID) has acquired 100% of Bhadla Ramgarh Power Transmission Limited, a project SPV, for an aggregate value of about Rs. 12.86 Crore (including 50,000 equity shares at par at Rs. 10 each along with assets and liabilities). The acquisition was made under the Tariff Based Competitive Bidding (TBCB) route for establishing an Inter-State Transmission system for augmentation at Bhadla-III, Ramgarh PS and Kanpur (PG) on a BOOT basis. The target entity was incorporated on 08.05.2026 and has no prior turnover, making this a greenfield project acquisition with no period-over-period financial comparisons available.
- · The project involves augmentation and bay extension works at Bhadla-III S/S (Rajasthan), Ramgarh S/S (Rajasthan) and Kanpur S/S (Uttar Pradesh).
- · The acquisition is not a related party transaction; prior to acquisition, POWERGRID had no interest in the target entity.
- · Approvals for Grant of Transmission License and Adoption of Transmission Charges are to be obtained from Central Electricity Regulatory Commission by Bhadla Ramgarh Power Transmission Limited after the acquisition.
- · The acquisition price is subject to adjustment as per the audited accounts of the company as on the acquisition date.
29-07-2026
The Committee of Independent Directors (IDC) of Niraj Cement Structurals Limited has recommended that shareholders accept the open offer from Gulshankumar Vijaykumar Chopra to acquire up to 1,55,20,529 equity shares (26.00% of voting capital) at ₹29.00 per share. The IDC considers the offer price fair and reasonable, noting it is higher than the volume-weighted average market price over the preceding 60 trading days. However, the IDC advises shareholders to independently evaluate the offer before making a decision.
- · The open offer is made under Regulation 3(1) of SEBI (SAST) Regulations, 2011.
- · The IDC members hold no equity shares in the target company and have no relationship with the acquirer.
- · No independent advisor was appointed by the IDC.
- · The offer price of ₹29.00 is justified based on the purchase consideration paid by the acquirer in share purchase agreements (SPAs) to sellers.
29-07-2026
ADF Foods Limited announced the incorporation of a wholly owned step-down subsidiary in Ireland, named ADF Foods Ireland Limited (or similar), to support its growth plans in Europe. The subsidiary will be held through its existing UK subsidiary, ADF Foods UK Limited, with an initial equity subscription of EUR 20,000 in cash. The filing does not include any financial performance data, so no period-over-period comparisons or negative metrics are available.
- · The subsidiary will be incorporated in Ireland under the name ADF Foods Ireland Limited or a similar name approved by Irish regulatory authorities.
- · The subsidiary will be a wholly owned step-down subsidiary of ADF Foods Limited, held through ADF Foods UK Limited.
- · The industry classification for the subsidiary is Processed Food Industry.
- · The incorporation is subject to necessary approvals and registrations under Irish law.
- · The consideration is cash, with an equity subscription of EUR 20,000.
29-07-2026
JK Cement Limited is investing ₹4,90,87,500 (₹4.91 Cr) in Mehrauni Electro Power Private Limited (MEPPL), subscribing 49,08,750 equity shares at ₹10 each, representing 18.31% post-allotment stake. The investment supports JK Cement's long-term renewable energy strategy by securing solar power supply for its Prayagraj plant through a group captive model. However, MEPPL is a recently incorporated SPV with no turnover and negative net worth of ₹(0.13) Cr as of March 2025, indicating early-stage financials.
- · MEPPL was incorporated in 2023 under CIN U35105DL2023PTC422273.
- · The solar power plant is located at Village-Bihariya, Tehsil-Bara, Prayagraj District, Uttar Pradesh.
- · The investment is made pursuant to a Second Supplementary Shareholders’ Agreement (SSHA).
- · The transaction is not a related party transaction and is at arm's length.
- · No governmental or regulatory approvals are required for the acquisition.
29-07-2026
UPL Limited has received 'no adverse observations' letters from BSE and NSE dated July 29, 2026, regarding its Composite Scheme of Arrangement involving UPL Sustainable Agri Solutions Limited, UPL Global Sustainable Agri Solutions Limited, and UPL Crop Protection Holdings Limited. The stock exchanges have imposed several conditions, including disclosure of pending adjudication proceedings, compliance with SEBI circulars, and ensuring financials in the scheme are not more than 6 months old. The scheme remains subject to other regulatory approvals, and the observation letters are valid for six months.
- · The observation letters from BSE and NSE are dated July 29, 2026.
- · The scheme involves four entities: UPL Limited (UPL 1), UPL Sustainable Agri Solutions Limited (UPL SAS), UPL Global Sustainable Agri Solutions Limited (UPL 2), and UPL Crop Protection Holdings Limited (UPL Cayman 1).
- · The company must disclose all details of ongoing adjudication, recovery proceedings, and enforcement actions against itself, promoters, and directors before NCLT and shareholders.
- · Financials in the scheme, including those for valuation, must not be more than 6 months old.
- · The listing of equity shares of UPL Global Sustainable Agri Solutions Limited is subject to SEBI granting relaxation under Rule 19(2)(b) of the Securities Contract (Regulation) Rules, 1957.
- · The validity of the observation letter is six months from July 29, 2026, within which the scheme must be submitted to NCLT.
- · The company must publish an advertisement with details of UPL Global Sustainable Agri Solutions Limited in newspapers.
- · Shares allotted pursuant to the scheme shall remain frozen in the depository system until listing/trading permission is given.
29-07-2026
Kesar India Limited has acquired 100% equity stake in Kesar Lands Private Limited (KLPL) for a total purchase consideration of ₹1,55,85,77,800 (₹155.86 Cr), to be paid via a share swap of up to 17,31,752 equity shares at ₹900 per share. KLPL, a related-party entity with zero turnover for the past three fiscal years, will become a wholly owned subsidiary. The acquisition aims to strengthen Kesar India's presence in real estate and infrastructure development.
- · KLPL was incorporated on October 19, 2026 (note: this date appears to be a typo in the filing as it is after the filing date of July 29, 2026; the CIN suggests incorporation in 2010).
- · KLPL's turnover for FY 2023-24, FY 2024-25, and FY 2025-26 was NIL.
- · The acquisition is a related-party transaction as KLPL is a related party, and the promoter group (Yash Gopal Gupta and Sangeeta Gopal Gupta) holds 100% of KLPL.
- · The share swap is subject to shareholder approval via a special resolution and in-principle approval from the stock exchange.
- · Completion of the acquisition is expected within 15 days from the later of shareholder approval or receipt of the last regulatory approval.
29-07-2026
ICSA (India) Ltd filed belated financial results for periods from FY2019-20 to FY2022-23, following the NCLT-ordered liquidation and subsequent closure of liquidation proceedings. The company reported persistent losses with zero revenue across all periods, with net losses widening from ₹558.81 Lakh in Q2 FY2020 to ₹4,869.76 Lakh in Q3 FY2020. The liquidation process realized ₹10,23,89,263 from asset sales, including ₹900.00 Lakh from land sold to Hyderabad Bottling Company, and the NCLT ordered closure of liquidation on February 7, 2023.
- · NCLT Hyderabad Bench ordered liquidation on August 18, 2020, and appointed Mr. Nethi Mallikarjuna Setty as Liquidator.
- · The liquidator was never provided control of documents by the erstwhile management, leading to accounts prepared based on available alternate evidence.
- · NCLT ordered closure of liquidation on February 7, 2023, via IA No. 215 of 2023, after sale of the corporate debtor as a going concern.
- · The newly appointed Board of Directors disclaims responsibility for financial oversight prior to acquisition.
- · The filing covers financial results for FY2019-20 through FY2022-23, all showing zero revenue and consistent losses.
29-07-2026
Rainbow Children's Medicare Limited (RCML) has executed definitive transaction documents to develop a new 100-bed children's and women's hospital in Malad, Mumbai through its subsidiary RWCHPL, with an estimated project cost of approximately ₹90 Crore. As part of the deal, RCML will dilute a 24% equity stake in RWCHPL to Fountainhead TCHM Healthcare LLP (promoted by three doctors), reducing its holding from 100% to 76% while retaining control. The hospital is expected to be commissioned by Q1 FY27-28, complementing a previously announced 150-bed Pune facility to build a hub-and-spoke network in Maharashtra. However, the subsidiary RWCHPL has negligible turnover (₹0.006 Crore in FY24-25 and ₹0.008 Crore in FY23-24) and a negative net worth of ₹(0.003) Crore, and the company's overall bed utilisation stands at only 46.3%.
- · RWCHPL's turnover declined 25% from ₹0.008 Crore in FY23-24 to ₹0.006 Crore in FY24-25.
- · RWCHPL has a negative net worth of ₹(0.003) Crore as of March 31, 2026.
- · The Malad hospital is a brownfield project expected to commence operations in Q1 FY28, while the Pune hub is expected in FY29.
- · RCML's existing bed utilisation is only 46.3% despite 2,435 beds.
- · The consideration for the 24% stake sale is only ₹24,000, indicating a nominal valuation for the subsidiary.
29-07-2026
RPG Life Sciences Ltd's board approved a three-part restructuring: (1) the slump sale of its API business to wholly owned subsidiary RPG Active Pharma Ltd (RPGAP) for ~₹33.55 Cr; (2) a ₹243.33 Cr investment by India Life Sciences Fund IV and Vistaject Fund for ~40% stake in RPGAP, with a commitment to infuse up to ₹700 Cr for organic and inorganic growth; and (3) RPGAP's acquisition of 100% of Actis Generics Private Ltd for ₹80 Cr. The API business contributed ₹95.06 Cr revenue (13.54% of consolidated turnover) in FY26, but Actis Generics' turnover declined sharply from ₹70.03 Cr in FY24 to ₹48.25 Cr in FY25, indicating a potential risk.
- · The Board meeting lasted only 15 minutes (8:30 pm to 8:45 pm).
- · The slump sale is expected to be completed on or before September 30, 2026.
- · The acquisition of Actis Generics is expected to be completed on or before November 15, 2026.
- · Actis Generics was incorporated on May 3, 2012, and is based in Visakhapatnam, India.
- · Actis Generics is a 'Bulk Drug Intermediates' company and a key Indian supplier for complex intermediates for APIs.
- · No change in the shareholding pattern of RPG Life Sciences is expected due to the slump sale.
- · The transaction is a related party transaction (slump sale to WOS) done at arm's length.
- · The acquisition of Actis Generics is not a related party transaction.
29-07-2026
Ocean Capital Acquisition Corp announced that holders of its IPO units may elect to separately trade the underlying ordinary shares, rights, and warrants starting August 3, 2026. The units will continue to trade under the symbol OCACU on the NYSE, while the separated components will trade under OCAC, OCACR, and OCACW. This is a procedural step enabling separate trading of the SPAC's securities components.
- · Separate trading of ordinary shares, rights, and warrants begins on August 3, 2026.
- · Holders must contact Odyssey Transfer and Trust Company LLC via their brokers to separate units.
- · The company is an emerging growth company as defined under SEC rules.
29-07-2026
Vista Credit Strategic Lending Corp. completed a tender offer to repurchase up to 2,401,540.880 shares of its common stock. The offer expired on July 23, 2026, with 873,765.843 shares validly tendered and accepted, representing 1.8% of shares outstanding. The company paid a total of $16,395,265.19 in cash, reflecting a net asset value per share of $19.13 less an early repurchase deduction. The filing highlights strong portfolio performance driven by a specialist focus on mission-critical software and disciplined underwriting since 2024, but the relatively low tender participation (1.8% of outstanding shares) suggests limited shareholder interest in selling at the offered price.
- · The tender offer was an issuer tender offer subject to Rule 13e-4, not a third-party offer.
- · The offer expired at 11:59 p.m. Eastern Time on July 23, 2026.
- · The company accepted 100% of validly tendered shares (no proration).
- · The early repurchase deduction was applied to the NAV per share, reducing the purchase price from the full NAV.
- · The filing emphasizes that the portfolio was largely deployed after 2024, benefiting from disciplined underwriting and lower leverage.
- · VCP believes it is operating from a position of strength with available capital to deploy selectively.
29-07-2026
Aureus Greenway Holdings Inc (AGH) is acquiring Autonomous Power Corporation (Powerus) via a stock-for-stock merger, with Powerus stockholders receiving approximately 599.18 AGH shares per Powerus share. The combined entity will be renamed Powerus Corporation and will operate both a golf country club business and an autonomous systems/defense technology business. The merger has been approved by written consent of both companies' stockholders and is expected to close by December 31, 2026, with up to 55 million earn-out shares now deemed vested at closing.
- · Exchange Ratio: 599.18229 shares of AGH Common Stock for each share of Powerus Common Stock.
- · End Date for closing: December 31, 2026, subject to extension.
- · Powerus stockholders approved the Merger Agreement on March 9, 2026 and Amendment No. 1 on July 21, 2026 via written consent.
- · AGH Board unanimously approved the Merger Agreement and the Merger.
- · Newco will be renamed 'Powerus Corporation' and will adopt a new equity incentive plan (2026 Powerus Corporation Equity Incentive Plan).
- · Litigation relating to the Merger is noted but not detailed in the provided excerpt.
29-07-2026
Catalyst Acquisition Corp., a blank check company, announced the pricing of its $200 million initial public offering of 20,000,000 units at $10.00 per unit, with units trading on Nasdaq under the symbol "CATLU" starting July 28, 2026. The offering is expected to close on July 29, 2026, and the company intends to focus on acquisition opportunities in traditional and digital media sectors, including video games and mobile gaming. The company has granted the underwriter a 45-day option to purchase up to an additional 3,000,000 units to cover over-allotments.
- · The units will trade on Nasdaq under the symbol "CATLU" starting July 28, 2026.
- · The Class A ordinary shares and rights are expected to begin separate trading no later than the 52nd day following the IPO date, under symbols "CATL" and "CATLR" respectively.
- · Santander is acting as sole book-running manager for the offering.
- · The company is a blank check company formed to pursue a business combination, with a focus on traditional and digital media sectors including video game companies, mobile gaming, publishers, studios, and media platforms.
- · The registration statement for the securities became effective on July 27, 2026.
29-07-2026
Medalist Diversified REIT, Inc. completed the acquisition of a 1.64-acre automotive service property in Overland Park, Kansas for $5.8 million in cash on July 29, 2026. The property was acquired through a Delaware statutory trust (DST), and the company plans to offer beneficial interests in the DST to accredited investors in a private placement, with proceeds used to redeem the company's interests. The acquisition was funded from cash on hand, and no debt or equity issuance was involved.
- · The acquisition was previously disclosed in a Form 8-K filed on June 9, 2026.
- · The seller was unaffiliated, and the transaction was at arm's length.
- · The DST was formed specifically to acquire and hold title to the property.
- · Financial statements and pro forma financial information will be filed within 71 days of this report.
29-07-2026
Foxx Development Holdings Inc. received a Nasdaq deficiency letter on July 22, 2026, for failing to meet the $35 million Market Value of Listed Securities (MVLS) requirement for continued listing on the Nasdaq Capital Market. The company has until January 19, 2027, to regain compliance by achieving an MVLS of at least $35 million for ten consecutive business days. While the company intends to monitor its market value and consider options, there is no assurance it will regain compliance, and failure could lead to delisting.
- · The company's common stock trades under ticker FOXX and warrants under FOXXW on Nasdaq.
- · The company is an emerging growth company and has not elected to use the extended transition period for new financial accounting standards.
- · The company was formerly known as Acri Capital Merger Sub I Inc. until February 29, 2024.
- · The company's principal executive offices are located in Irvine, CA.
29-07-2026
Celularity Inc. received a Nasdaq notice on July 23, 2026, for failing to meet the minimum bid price of $1.00 per share for 30 consecutive business days. The company has a 180-day cure period until January 19, 2027, to regain compliance, but there is no assurance of success. This delisting risk highlights a significant negative development for the company's stock and financial standing.
- · The company's Class A common stock continues to trade on the Nasdaq Capital Market under the symbol 'CELU' with no immediate effect on listing.
- · If compliance is not regained by January 19, 2027, the company may be eligible for an additional 180-day grace period if it meets other listing standards except the bid price requirement.
- · The company will evaluate available options but cannot assure regaining compliance.
Get daily alerts with 11 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Global High-Priority Regulatory Events
🇺🇸 More from United States
View all →July 31, 2026
US Pre-Market SEC Filings Roundup — July 31, 2026
US Pre-Market SEC Filings Roundup
July 31, 2026
USA Corporate Events Calendar — July 31, 2026
USA Corporate Events Calendar
July 31, 2026
USA Earnings Calls Schedule — July 31, 2026
USA Earnings Calls Schedule
July 31, 2026
US Merger & Acquisition SEC Filings — July 31, 2026
US Merger & Acquisition SEC Filings